NCT06276491 2026-03-17Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsXencor, Inc.Phase 1 Recruiting282 enrolled
NCT05238883 2025-11-21A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsHiFiBiO TherapeuticsPhase 1 Active not recruiting72 enrolled